Clinical trial
Clinical Study of Granulocyte Colony-stimulating Factor (G-CSF)-Primed, Peripheral-blood Progenitor Cells for the Prevention of Relapse Advanced Stage Leukemia
NCT01455272 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Granulocyte Colony-stimulating Factor (G-CSF)-Primed, Peripheral-blood Progenitor Cells for the Prevention of Relapse Advanced Stage Leukemia
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- March 31, 2015
- Enrollment
- 100 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.